254 related articles for article (PubMed ID: 17997752)
1. Results of immunotherapy for patients with unexplained primary recurrent abortions--prospective non-randomized cohort study.
Nonaka T; Takakuwa K; Ooki I; Akashi M; Yokoo T; Kikuchi A; Tanaka K
Am J Reprod Immunol; 2007 Dec; 58(6):530-6. PubMed ID: 17997752
[TBL] [Abstract][Full Text] [Related]
2. Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization.
Malinowski A; Wilczynski J; Zeman K; Glowacka E; Kolasa D; Szpakowski A; Oszukowski P; Szpakowski M
Zentralbl Gynakol; 1998; 120(10):493-502. PubMed ID: 9823650
[TBL] [Abstract][Full Text] [Related]
3. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.
Pandey MK; Agrawal S
Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420
[TBL] [Abstract][Full Text] [Related]
4. Result of immunotherapy on patients with unexplained recurrent abortion: a beneficial treatment for patients with negative blocking antibodies.
Takakuwa K; Goto S; Hasegawa I; Ueda H; Kanazawa K; Takeuchi S; Tanaka K
Am J Reprod Immunol; 1990 Jun; 23(2):37-41. PubMed ID: 2145853
[TBL] [Abstract][Full Text] [Related]
5. Results of immunotherapy for patients with unexplained secondary recurrent abortions.
Adachi H; Takakuwa K; Mitsui T; Ishii K; Tamura M; Tanaka K
Clin Immunol; 2003 Mar; 106(3):175-80. PubMed ID: 12706403
[TBL] [Abstract][Full Text] [Related]
6. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion.
Khonina NA; Broitman EV; Shevela EY; Pasman NM; Chernykh ER
Arch Gynecol Obstet; 2013 Oct; 288(4):933-7. PubMed ID: 23558562
[TBL] [Abstract][Full Text] [Related]
7. Is an additional vaccination necessary for a successful second pregnancy in unexplained recurrent aborters who were successfully immunized with their husband's lymphocytes before the first pregnancy?
Takakuwa K; Higashino M; Yasuda M; Ishii S; Ueda H; Asano K; Kazama Y; Tanaka K
Am J Reprod Immunol; 1993 Jan; 29(1):39-44. PubMed ID: 8503994
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of leukocyte immunotherapy in primary recurrent spontaneous abortion (RSA).
Gharesi-Fard B; Zolghadri J; Foroughinia L; Tavazoo F; Samsami Dehaghani A
Iran J Immunol; 2007 Sep; 4(3):173-8. PubMed ID: 17767017
[TBL] [Abstract][Full Text] [Related]
9. Relationship between MLR blocking antibodies and the outcome of the third pregnancy in patients with two consecutive spontaneous abortions.
Tamura M; Takakuwa K; Arakawa M; Yasuda M; Kazama Y; Tanaka K
J Perinat Med; 1998; 26(1):49-53. PubMed ID: 9595367
[TBL] [Abstract][Full Text] [Related]
10. [Efficiency of lymphocyte immunization by the partner in prevention of unexplained recurrent spontaneous abortion. II. Immunologic prognostic factors].
Malinowski A; Zeman K; Banasik M; Głowacka E; Wilczyński J; Pokoca L; Puchała B; Szpakowski M
Ginekol Pol; 1997 Apr; 68(4):173-80. PubMed ID: 9463081
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization.
Beer AE; Semprini AE; Zhu XY; Quebbeman JF
Exp Clin Immunogenet; 1985; 2(3):137-53. PubMed ID: 2978830
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal-fetal immuno-recognition].
Li D; Li C; Zhu Y
Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):597-600. PubMed ID: 10806684
[TBL] [Abstract][Full Text] [Related]
13. Immunological studies in recurrent spontaneous abortion: effects of immunization of women with paternal mononuclear cells on lymphocytotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA and pregnancy outcome.
Smith JB; Cowchock FS
J Reprod Immunol; 1988 Nov; 14(2):99-113. PubMed ID: 2976829
[TBL] [Abstract][Full Text] [Related]
14. [The management of unexplained recurrent abortions. Is immunotherapy an option?].
Constantinescu D; Cozmei C; Dumitraşcu I; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):371-8. PubMed ID: 19295006
[TBL] [Abstract][Full Text] [Related]
15. [Analysis on the CTL-p frequency before and after immunotherapy for patients with unexplained habitual abortion].
Yamada K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jun; 45(6):527-32. PubMed ID: 8315311
[TBL] [Abstract][Full Text] [Related]
16. Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband's mononuclear cells.
Yokoo T; Takakuwa K; Ooki I; Kikuchi A; Tamura M; Tanaka K
Fertil Steril; 2006 May; 85(5):1452-8. PubMed ID: 16647376
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of MLR blocking antibodies before and after immunotherapy.
Agrawal S; Pandey MK; Pandey A
J Hematother Stem Cell Res; 2000 Apr; 9(2):257-62. PubMed ID: 10813539
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with paternal lymphocytes preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer.
Hasegawa I; Tani H; Takakuwa K; Yamada K; Kanazawa K; Tanaka K
Fertil Steril; 1992 Feb; 57(2):445-7. PubMed ID: 1531202
[TBL] [Abstract][Full Text] [Related]
19. Analysis of anti-lymphocyte antibodies by flow cytometry or microlymphocytotoxicity in women with recurrent spontaneous abortions immunized with paternal leukocytes.
Gilman-Sachs A; Luo SP; Beer AE; Beaman KD
J Clin Lab Immunol; 1989 Oct; 30(2):53-9. PubMed ID: 2534916
[TBL] [Abstract][Full Text] [Related]
20. Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss.
Clark DA
Am J Reprod Immunol; 2009 Jan; 61(1):75-84. PubMed ID: 19086995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
